Skip to main content
OpenTrials

Clinical trial condition

Autoimmune Diseases

Explore clinical trials studying Autoimmune Diseases. Study availability and eligibility vary by location and protocol.

10,901 public trials 1,659 recruiting studies
Refine in advanced search Browse all conditions

Autoimmune Diseases trial results

Completed

Vista Protein Expression of Monocyte and T Cell Subsets in Multiple Sclerosis and Its Clinical Correlation

NCT06957145

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • Koc University Istanbul, Turkey (Türkiye)
  • Bakirkoy Prof. Dr. Mazhar Osman Training and Research Hospital for Psychiatric, Neurologic and Neurosurgical Diseases, University of Health Sciences, Istanbul, Turkey Istanbul, Turkey (Türkiye)
View Trial Details
Completed

A Randomized, Controlled, Safety and Tolerability Study of VRDN-001 in Participants With Thyroid Eye Disease (TED)

NCT06384547

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations
  • United Medical Research Institute Inglewood, California, United States
  • Advancing Research International, LLC Los Angeles, California, United States
  • Stanford Byers Eye Institute Palo Alto, California, United States
  • Cockerham Eye Consultants, PC San Diego, California, United States
View all 50 locations
View Trial Details
Completed

An Efficacy, Safety, and Tolerability Study of Veligrotug (VRDN-001), in Participants With Chronic Thyroid Eye Disease (TED)

NCT06021054

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations
  • Advancing Research International, LLC Los Angeles, California, United States
  • USC Roski Eye Institute Los Angeles, California, United States
  • Amy Patel Jain, MD Newport Beach, California, United States
  • Stanford Byers Eye Institute Palo Alto, California, United States
View all 57 locations
View Trial Details
Completed

Open-Label Extension of Zilucoplan in Subjects With Generalized Myasthenia Gravis

NCT04225871

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • Mg0011 41 Mobile, Alabama, United States
  • Mg0011 116 Phoenix, Arizona, United States
  • Mg0011 31 Irvine, California, United States
  • MG0011 4 Los Angeles, California, United States
View all 70 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Thyroid Eye Disease

NCT06106828

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations
  • Plastics-Orbit-Neuro San Diego, California, United States
  • Connecticut Eye Consultants, P.C. Danbury, Connecticut, United States
  • University of Illinois Eye and Ear Infirmary Chicago, Illinois, United States
  • Scheie Eye Institute Philadelphia, Pennsylvania, United States
View all 41 locations
View Trial Details
Completed

A Phase III, Non-Inferiority, Randomized, Open-Label, Parallel Group, Multicenter Study To Investigate The Pharmacokinetics, Pharmacodynamics, Safety And Radiological And Clinical Effects Of Subcutaneous Ocrelizumab Versus Intravenous Ocrelizumab In Patients With Multiple Sclerosis

NCT05232825

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +11 more
Locations
  • Neurology Associates PA Maitland, Florida, United States
  • University of South Florida Tampa, Florida, United States
  • Johns Hopkins Hospital Baltimore, Maryland, United States
  • Memorial Healthcare Institute for Neurosciences and Multiple Sclerosis Owosso, Michigan, United States
View all 37 locations
View Trial Details

Related conditions